Reshape the medical industry 14 innovative medical equipment technology
Programs for Public Good
Medical devices are changing every aspect of global healthcare, from IoT technology to 3D printing, and new and innovative medical devices are gaining traction with healthcare facilities and patients' homes. While the industry as a whole is under pressure to reduce health care expenditures, diversify competition and improve care, the overall outlook for the health care industry will be objective.
Emerging technologies and patients with high espionage rights are driving changes in this dynamic market.
WHO defines medical devices as articles, instruments, devices, or machines used to prevent, diagnose, or treat a disease, or to detect, measure, recover, correct, or improve the structure or function of a body for any health purpose. Innovative medical devices can be as simple as basic laboratory equipment or as complex as CT scanners.
Currently, the top two medical device innovators, the United States and Germany, export 36% of the world's medical devices and provide products and services to large economies such as China, Japan, Mexico, Canada and the European Union. The global medical device technology market is projected to be 458.3 billion U.S. dollars in 2015, rising from a CAGR of 5.6% from 2016 to 2021 and reaching 634.5 billion U.S. dollars by 2021.
By focusing on products that are clinically significant for the treatment of patients compared to current practice, BizVibe summarizes 14 medical devices that are either already on the market or are on the market. These innovative medical products have strong user engagement to improve healthcare. Each of the innovative medical devices in this list can change modern healthcare and promote the development of patient-centered health care models.
01, mixed closed-loop insulin delivery system
Patients with type 1 diabetes will be helped by a new medical device technology known as the world's first artificial pancreas. Unlike the old open-loop technology, the new device has three separate systems that allow for direct communication between the monitoring device and the insulin pump, eliminating the need for a patient's 2-4-pin calibration routine and stabilizing blood glucose levels at an unprecedented rate.
One study showed that with this device, the average blood glucose level of adolescents dropped from 7.7% to 7.1% and the adult blood glucose level dropped from 7.3% to 6.8%. The FDA approved the technology in late 2016 and as more insurers begin to cover the product, the market for this technology will be even greater in 2018. At the same time, experts are optimistic that this technology will also bring similar applications for patients with type 2 diabetes may.
02, a method of neuromodulation for treating obstructive sleep apnea
The new implantable medical device is helping rest more than 21 million U.S. patients with obstructive sleep apnea. Unlike previous CPAP devices, which are implanted through minimally invasive surgery, the sensing system perceives the breathing pattern and provides mild stimulation to the tongue and throat to keep the patient's airway fluid .
This innovative medical device can be controlled remotely by the patient or with wearable devices and can act as a pacemaker to synchronize the inhalation of air with the action of the tongue. Positive clinical test results show that the system can significantly reduce the occurrence of sleep apnea events and decline in blood glucose.
03, gene therapy of hereditary retinal diseases
Patients with a variety of rare inherited retinal diseases (IRDS) are expected to be able to get some effective treatment by 2018, especially for those with a lack of treatment experience that can lead to a serious decline in patients' vision. Innovative gene therapy, which is to be approved, can provide patients with a normal copy of the gene that normalizes the function of the protein. The researchers introduced the functional gene into a modified virus and then delivered it to retinal cells.
The application of gene therapy in the medical community has been slow, but some experts predict that the gene therapy will be more developed as the gene therapy is approved by the FDA. In 2017, the FDA awarded orphan drug for RPE65 gene therapy, and in October, the US Health Advisory Group also recommended approval of the therapy.
04, Innovative Tool Against LDL Cholesterol
Low-density lipoprotein cholesterol leads to the death of 400,000 coronary heart disease patients each year, but with this new medical tool, 102 million high-cholesterol American patients will receive better treatment. As a new anti-cholesterol drug, PCSK9 inhibitor can reduce cardiovascular mortality by 20% at the same time by taking statins, with myocardial infarction and stroke up to 20%.
This new cholesterol-lowering drug offers doctors and researchers more options to beat low-density lipoprotein cholesterol.
05, remote diagnosis and treatment technology
The geographical barriers and long waiting times that exist in hospitals and other medical facilities offer the potential for telemedicine technology. The development of mobile technologies and increased consumer demand have helped widespread adoption of telemedicine. It is reported that 90% of medical managers are or have established a telemedicine project.
Other innovative telemedical devices include attachable and wearable devices that monitor, record and report information to medical providers. More than 19 million patients are expected to use these remote monitoring devices in 2018 and 7 million will use telemedicine services, nearly 19 times the level in 2013.
06, a new generation of vaccine platform
At this stage, it may take at least 10 years to develop a vaccine and cost 200 million U.S. dollars. 2018 will be a year of improvement as innovation researchers have upgraded the entire vaccine infrastructure to support the rapid growth of new vaccines and will also update innovative mechanisms to provide new and existing Vaccine products.
Unlike hatchery-based vaccines, researchers are using tobacco plants, insects and nanoparticles for vaccine development, which will save millions of dollars in development costs and precious time. These new methods of developing, shipping, storing and managing vaccines are being implemented to prevent the spread of the current and future epidemics.
07, to promote postoperative recovery (ERAS)
Promote postoperative recovery refers to a multimodal, multidisciplinary approach to care in patients undergoing surgery. Use equipment and methods to help reduce rehospitalization and recurrence risks. The new rehabilitation program has proven to reduce hospitalization time by 30% to 50%, with the same reduction in complications, readmissions and costs.
A study involving 9,000 surgeries showed that ERAS reduces postoperative morbidity by one third and reduces prescriptions for opiates by 21%, as well as mortality from colorectal resection . The study also showed a higher rate of discharge from patients with hip fractures rather than staying in a nursing environment. Other ERAS studies show that with ERAS, care costs per patient can be reduced by $ 6,500.
08, intensive monitoring of hospitalized patients
New, innovative medical monitoring devices using advanced devices have emerged, such as sensors and HD cameras to monitor each patient's blood pressure, heart rate, respiratory rate, pulse rate, oxygen saturation, and more. These complex monitoring data are then aggregated and, if anything is wrong, on-site interventions are triggered and the trivial alerts are filtered out. Prior to the intensive surveillance program, the American Heart Association reported that as many as 44% of hospitalized cardiac arrests were not properly monitored, mainly due to "alert fatigue" experienced by nurses who are less sensitive to the telemetry monitoring system To
A 2016 study showed that 93% of patients with a centrally controlled system who experienced cardioversion had a higher survival rate. Since then, further innovations have brought systems that double the number of patients monitored, while improving clinical outcomes, reducing transit times, and continually improving the ability to save patients.
09, scalp cooling technique for reducing hair loss caused by chemotherapy
Since being approved by the FDA in May 2017, the new scalp cooling system is being used in hospitals around the world. The hair loss prevention system reduces the biochemical activity by using a helmet with a cooling liquid to keep the scalp cold. Experts believe that this innovative medical device reduces the cellular uptake of chemotherapeutic drugs and / or reduces the hair follicle's susceptibility to chemical damage.
In clinical trials, the patient wore the scalp for a period of 30 minutes before chemotherapy, chemotherapy, and 90 minutes after chemotherapy. Interim results showed that 48-95% of patients in the intervention group were able to maintain their hair while none of the 47 patients in the control group were able to maintain their hair.
10, a broadband medical radar for breast cancer imaging
Mammography is painful and invasive, but a new broadband medical radar, such as the koning corp breast CT 1000 with microwave imaging, will revolutionize mammography. This quick and easy-to-use medical technique allows patients to sit comfortably in less than a minute on their chairs. The system uses multiple antennas to scan the breast with very low power radio waves to produce 3D images.
Traditional mammography costs nearly $ 250,000, but a medical radar costs only 1/10 the cost of an X-ray device and can benefit patients even more.
CardioMEMS heart failure monitoring system
This is the first and only heart failure monitor FDA has approved to improve the quality of life and reduce hospitalization for an average of 18 months. The system features a small pressure sensing device implanted directly into the pulmonary artery, can send information to your doctor, and then adjust the treatment according to the information in real time.
This innovative medical device includes many features: An easy-to-use home electronics unit sends information instantly and wirelessly to your doctor to make changes to your treatment before you feel the symptoms. The sensor does not require batteries or replaceable parts.
12, three-dimensional biological tissue printing
Several universities around the world have developed bio-printers that can print biological tissue for the vascular, myocardial patch, nerve, and organ and skeletal transplant needs. 3D printing is a major medical innovation. Printed repair cells grow with the patient's own cells, providing a perfect match without having to re-use foreign tissues or organs.
In December 2016, the California-based Organovo Corporation demonstrated for the first time the survival and functionality of a 3D bio-printed human liver tissue in animal models. Organovo plans to submit its listing application for liver tissue to the FDA in 2020.
BrainScope One, a measure of brain damage
BrainScope One is an FDA-approved innovative medical device that assesses the extent of head injury. This revolutionary medical device is simple in construction and uses noninvasive electroencephalography to provide brain damage assessment for patients with craniocerebral injury within 3 days. BrainScope One measures and interprets the patient's brain electrical activity and neurocognitive function while generating objective data.
This powerful emergency care tool makes clinical diagnosis accurate and rapid. Every year in the United States, there are about 5 million patients with closed head injuries, most of whom do not receive medical attention. Most patients underwent CT scans, 90% of which are the result of a negative structural brain injury, with radiation exposure. BrainScope One will significantly reduce radiation exposure and latency and reduce hospital treatment costs, eliminating unnecessary CT scans.
14, attune® Total Knee Replacement System
The innovative medical device from Johnson & Johnson subsidiary DePuySynthes, can help patients to restore total knee activity. The joint reconstruction unit is DePuy Synthes' largest research and development project ever built, incorporating the latest engineering, design, kinematics and materials science to provide stability and mobility to postoperative patients with knee surgery.
The device reduces the radius of the femur to achieve a smooth transition from stability to rotational freedom. It uses soft tissue interaction while optimizing patella trajectory and maintaining bone coverage. This total knee system combines intuitive features that combine the surgical procedure with an effective tool that helps surgeons balance soft tissue and control implant placement.